Information  X 
Enter a valid email address

Westpac Sec NZ Ltd (94WF)

  Print   

Thursday 02 December, 2021

Westpac Sec NZ Ltd

Publication of a Prospectus

RNS Number : 4419U
Westpac Securities NZ Ltd
02 December 2021
 

WESTPAC SECURITIES NZ LIMITED

 

Update of US$ 10,000,000,000 Programme for the Issuance of Debt Instruments
unconditionally and irrevocably guaranteed by Westpac New Zealand Limited

 

Westpac Securities NZ Limited has updated its US$ 10,000,000,000 programme for the issuance of debt instruments unconditionally and irrevocably guaranteed by Westpac New Zealand Limited (the "Programme").

 

The base prospectus in relation to the Programme is dated 2 December 2021 (the "Prospectus") and has been approved by the UK Financial Conduct Authority.

 

To view the full document, please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/4419U_1-2021-12-2.pdf

 

A copy of the Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

 

For further information, please contact:

Leisha White
Westpac Securities NZ Limited (London branch)
Camomile Court
23 Camomile Street
London  EC3A 7LL

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed.  Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

This publication does not constitute an offering of debt instruments (the "Instruments") or the guarantee (the "Guarantee") thereof, and is not for distribution in or into the United States. The Instruments and the Guarantee of the Instruments have not been and will not be registered under the United States Securities Act of 1933 as amended (the "Securities Act"), or any relevant securities laws of any state of the United States and, subject to certain exceptions, the Instruments may not be offered, sold or delivered in the United States or to, or for the account or benefit of, U.S. persons, as such terms are defined in Regulation S under the Securities Act.  Instruments (and the Guarantee thereof) in bearer form are subject to U.S. tax law requirements and may not be offered, sold or delivered within the United States or its possessions or to a U.S. person, except in certain transactions permitted by U.S. tax regulations.  Terms used in the preceding sentence have the meanings given to them by the U.S. Internal Revenue Code and regulations thereunder. There will be no public offering of the Instruments or the Guarantee of the Instruments in the United States.

Your right to access this service is conditional upon complying with the above requirement.  In particular, your accessing this service will constitute your representation that you are not in the United States and you are not a U.S. person within the meaning of Regulation S under the Securities Act and the U.S. Internal Revenue Code and regulations thereunder.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIDLLFBFLLLFBV

a d v e r t i s e m e n t